AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Lamivudine; Tenofovir Disoproxil Fumarate in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Lamivudine & Tenofovir Disoproxil Fumarate Tablets 300/300 mg Film coated tablet | A4-100080 | Ranbaxy Nigeria Limited | active | 25 Aug 2026 |
| Tenofovir Disoproxil Fumarate/ Lamivudine Tablets Tablet | A4-3126 | Healthline Limited | active | 9 Nov 2025 |
Lamivudine; Tenofovir Disoproxil Fumarate — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Lamivudine; Tenofovir Disoproxil Fumarate, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Lamivudine; Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.